Aprogen Pharmaceuticals Inc (003060) — Net Asset Quality Index
Aprogen Pharmaceuticals Inc (003060) has a Net Asset Quality Index of 52.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩603.42 Billion minus total liabilities of ₩288.27 Billion yields net assets of ₩315.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Aprogen Pharmaceuticals Inc (003060) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Aprogen Pharmaceuticals Inc Net Asset Quality Index Over Time (2009–2024)
This chart shows how Aprogen Pharmaceuticals Inc's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2024. As of September 2025, the index stands at 52.2%, representing net assets of ₩315.16 Billion against total assets of ₩603.42 Billion KRW. For live market cap and overall valuation, see 003060 stock market capitalisation.
Annual Net Asset Quality Index for Aprogen Pharmaceuticals Inc (2009–2024)
The table below presents the year-by-year Net Asset Quality Index for Aprogen Pharmaceuticals Inc from 2009 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of Aprogen Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 64.1% | ₩378.69 Billion | ₩590.98 Billion | ₩212.29 Billion | ▲ +1.5 pp |
| 2023 | 62.6% | ₩368.69 Billion | ₩589.40 Billion | ₩220.71 Billion | ▼ -12.1 pp |
| 2022 | 74.6% | ₩510.41 Billion | ₩684.14 Billion | ₩173.73 Billion | ▼ -22.6 pp |
| 2021 | 97.2% | ₩597.18 Billion | ₩614.62 Billion | ₩17.44 Billion | ▼ -0.1 pp |
| 2020 | 97.2% | ₩598.36 Billion | ₩615.31 Billion | ₩16.95 Billion | ▲ +2.1 pp |
| 2019 | 95.2% | ₩347.64 Billion | ₩365.28 Billion | ₩17.65 Billion | ▲ +25.8 pp |
| 2018 | 69.3% | ₩150.51 Billion | ₩217.06 Billion | ₩66.55 Billion | ▲ +20.1 pp |
| 2017 | 49.2% | ₩77.86 Billion | ₩158.27 Billion | ₩80.41 Billion | ▼ -11.5 pp |
| 2016 | 60.7% | ₩78.12 Billion | ₩128.69 Billion | ₩50.57 Billion | ▼ -18.8 pp |
| 2015 | 79.5% | ₩67.75 Billion | ₩85.22 Billion | ₩17.48 Billion | ▲ +6.3 pp |
| 2014 | 73.2% | ₩62.11 Billion | ₩84.83 Billion | ₩22.71 Billion | ▲ +1.0 pp |
| 2013 | 72.3% | ₩56.55 Billion | ₩78.26 Billion | ₩21.71 Billion | ▼ -1.3 pp |
| 2012 | 73.6% | ₩68.51 Billion | ₩93.08 Billion | ₩24.58 Billion | ▲ +10.4 pp |
| 2011 | 63.2% | ₩73.49 Billion | ₩116.33 Billion | ₩42.85 Billion | ▲ +8.8 pp |
| 2010 | 54.4% | ₩42.81 Billion | ₩78.70 Billion | ₩35.89 Billion | ▼ -6.8 pp |
| 2010 | 61.2% | ₩41.38 Billion | ₩67.64 Billion | ₩26.26 Billion | ▲ +18.5 pp |
| 2009 | 42.6% | ₩25.18 Billion | ₩59.07 Billion | ₩33.89 Billion | — |